GeoVax Labs, Inc. (GOVX) vs Nuwellis, Inc. (NUWE)
A side-by-side comparison of GeoVax Labs, Inc. and Nuwellis, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
GOVX
GeoVax Labs, Inc.
$0.31HealthcareDelayed quote: Oct 6, 2026, 12:12 PM EDT
NUWE
Nuwellis, Inc.
$0.72HealthcareDelayed quote: Oct 6, 2026, 12:14 PM EDT
Total return — GOVX vs NUWE
growth of $100 · dividends reinvested · last 8yGOVX -100.0% (-82.3%/yr)NUWE -100.0% (-77.2%/yr)NUWE compounded faster over this window
Log scale — wide-divergence pair
GOVX NUWE
GOVX vs NUWE: by the numbers
- •NUWE is the larger company ($3M vs $2M market cap).
- •Both run net losses; NUWE's is the smaller (-123.38% vs -862.34% net margin).
Metrics side by side
Valuation
| Metric | GOVX | NUWE |
|---|---|---|
| P/S ratio | N/A | 0.29 |
| P/B ratio | 1.28 | N/A |
Profitability
| Metric | GOVX | NUWE |
|---|---|---|
| Gross margin | -628.02% | 69.69% |
| Operating margin | -869.34% | -140.62% |
| Net margin | -862.34% | -123.38% |
| ROE | -1160.10% | N/A |
| ROIC | -985.20% | -238.32% |
Growth (annualized)
| Metric | GOVX | NUWE |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 1.48% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.